tirzepatide south africa available in SA 🚫 PUBLIC WARNING‼️‼️ Health regulators

Chemie Int

This clinical trial called the therapeutic effect of semaglutide in obese patients has passed phase 1 and phase 2 clinical trials, but the safety of the 2.4 mg dose still needs to be evaluated

Side effects with Wegovy 7.2 mg The STEP UP trial found that side effects were somewhat more common at the higher dose: 2 GI side effects: 70.8% (7.2 mg) vs 61.2% (2.4 mg) Dysaesthesia (tingling/numbness): 22.9% (7.2 mg) vs 6.0% (2.4 mg) Discontinuation due to side effects remained low at 3.3% The dysaesthesia finding is notable, though 85.7% of cases resolved while continuing treatment

Shelf life: 24 months, properly stored, in a sealed container